ACTA1 and Hepatic fibrosis: Besides, AG490-pretreated UC-MSCs displayed an enhanced therapeutic efficacy in DDC-induced liver fibrosis model, as shown by HE, PSR staining and α-SMA staining, compared to normal UC-MSCs (Fig. 6C).